Wuhan Tonggan Medical — Pioneering Bio-Artificial Liver Manufacturing Base

Full-Scale EPC for Bio-Medical Facilities & Process Equipment Integration Achievement

Support for China’s First Clinically Approved Bio-Artificial Liver Technology

Scale:1,500sqm

Project Overview

A National Landmark for Clinical Bio-Artificial Liver Industrialization

Engineering China’s first regulatory-approved and clinical-ready industrialization base for bio-artificial liver technology.

AIPURE served as the general contractor for the complete purification and mechanical/electrical (M&E) infrastructure of this pioneering facility for Tonggan Medical. The project involved the strategic procurement and precision installation of both public utilities and specialized process equipment. Designed to support the large-scale production of clinical-grade bio-artificial livers, this base represents a breakthrough in high-containment, sterile bioprocessing, ensuring a high-standard clean space for life-saving medical technology.

Technical Highlights

  • Clinical-Grade Sterility: Engineered to meet the the specified cleanliness standards required for sensitive cell culture and product formulation.

  • Total GMP Validation Support: Comprehensive assistance throughout the entire design, construction, and commissioning phases to support the client’s GMP certification process.

  • High-Containment Biosafety: Implementation of rigorous cross-contamination controls to protect both the biological products and the manufacturing environment.

  • Intelligent System Linkage: Full integration of cleanroom HVAC, biosafety protocols, process equipment, and real-time environmental monitoring systems.

Engineering Challenges & Solutions

  • Stringent Biosafety & Contamination Control: Producing bio-artificial livers involves complex cell cultivation that is extremely sensitive to microbes and particulates. We engineered a high-precision cleanroom system with stabilized pressure gradients and precise thermal regulation to minimise cross-contamination risk during production.

  • Comprehensive Lifecycle GMP Compliance: Meeting clinical-grade production standards requires total traceability. AIPURE managed every detail—from material selection to equipment installation and system debugging—providing full documentation and validation support to help the client achieve GMP certification.

  • Multi-System Integrated Stability: The facility requires seamless synchronization between public utilities, specialized process machinery, and environmental monitoring. We executed an integrated installation model, ensuring that all systems operate as a unified, stable entity for continuous clinical-grade manufacturing.

  • Clinical-Grade Safety & Reliability: To guarantee product safety, we implemented a “risk-controlled” construction protocol, focusing on high-integrity airtightness and biosafety integrity across all sterile zones, ensuring the facility is fully audit-ready for medical regulatory inspections.

Construction Content

  • Clinical-Grade Cell Culture Suites: High-standard cleanrooms optimized for biological cell growth and processing.

  • Process Equipment Integration: Precision procurement and installation of specialized bio-manufacturing hardware.

  • Sterile HVAC & Air Purification: Advanced air handling systems designed for stringent particulate and microbial control.

  • Integrated Environmental Monitoring (EMS): Digital systems for real-time tracking and recording of critical cleanroom parameters.

Why This Project Defines AIPURE

“Engineering the sterile foundations for the future of regenerative medicine.”

The Tonggan Medical project showcases AIPURE’s mastery in “Clinical-Grade Bio-Engineering.” By delivering China’s first production base for bio-artificial livers that passed GMP certification, we prove our ability to provide the secure, compliant, and mass-production-ready infrastructure required for the most advanced medical breakthroughs.

Project Conclusion

The successful high-standard delivery of the Tonggan Medical base has enabled the client to achieve full industrialization of their bio-artificial liver technology. Our integrated management ensured that every technical indicator met the design benchmarks for clinical therapy. At AIPURE, we don’t just build cleanrooms; we build the high-precision, life-protecting infrastructure that brings revolutionary medical treatments from the lab to the patient.

VIEW MORE PROJECTS

Related Service

Cleanroom Consulting

Cleanroom Design

Construction

Product Manufacturing

Commissioning

Operation & Maintain

Contact Information

Global Sales & Technical Support

+86 15607108630

WhatsApp Support

+86 15607108630

China Headquarter Address

No 18 Finance Harbor 4th Road, Wuhan, China.

Request a Tailored Proposal

We respond to technical inquiries within 24 hours.

Scroll to Top